|
The
net loss and the weighted average number of shares used in computing basic and diluted net loss per share for the period of six
month ended June 30, 2021 and 2020, is as follows:
SCHEDULE OF WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES
| |
|
2021 |
|
|
2020 |
|
| |
|
Six month period ended |
|
| |
|
2021 |
|
|
2020 |
|
| |
|
|
|
|
|
|
| Numerator: |
|
|
|
|
|
|
|
|
| Net loss attributable to common shareholders |
|
$ |
14,167 |
|
|
$ |
7,223 |
|
| Revaluation of liability related to warrants to purchase shares of common stock |
|
|
- |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| Net loss attributable to common shareholders |
|
$ |
14,167 |
|
|
$ |
7,223 |
|
| |
|
|
|
|
|
|
|
|
| Denominator: |
|
|
|
|
|
|
|
|
| Shares of common stock used in computing basic net loss per share |
|
|
585,225,006 |
|
|
|
164,423,927 |
|
| Incremental shares from assumed exercise of warrants to purchase shares of common stock |
|
|
- |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| Shares of common stock used in computing diluted net loss per share |
|
|
585,225,006 |
|
|
|
164,423,927 |
|
| |
|
|
|
|
|
|
|
|
| Net loss per share of common stock, basic and diluted |
|
$ |
0.02 |
|
|
$ |
0.04 |
|
|